Seroatlas · Human Serome Atlas

SLC7A5

Large neutral amino acids transporter small subunit 1

Also known as: CD98, D16S469E, E16, LAT1, LAT1_HUMAN, MPE16

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q01650
Gene
SLC7A5
Ensembl
ENSG00000103257
Chromosome
16
Canonical length
507 aa
Protein class
Metabolic proteins, Predicted membrane proteins, Transporters
Subcellular location
Vesicles,Plasma membrane,Cytosol

OverviewNCBI Gene

Enables L-amino acid transmembrane transporter activity and secondary active transmembrane transporter activity. Involved in carboxylic acid transport; thyroid hormone transport; and xenobiotic transport. Located in several cellular components, including apical plasma membrane; cytosol; and microvillus membrane. Part of amino acid transport complex. Implicated in cholangiocarcinoma; colon cancer; hepatocellular carcinoma; and lung squamous cell carcinoma. Biomarker of esophagitis; gastrointestinal system cancer (multiple); malignant astrocytoma (multiple); and respiratory system cancer (multiple). [provided by Alliance of Genome Resources, Apr 2025]

Canonical amino-acid sequenceUniProt

507 residues, UniProt reviewed canonical sequence.

>Q01650|SLC7A5
     1  MAGAGPKRRA LAAPAAEEKE EAREKMLAAK SADGSAPAGE GEGVTLQRNI TLLNGVAIIV
    61  GTIIGSGIFV TPTGVLKEAG SPGLALVVWA ACGVFSIVGA LCYAELGTTI SKSGGDYAYM
   121  LEVYGSLPAF LKLWIELLII RPSSQYIVAL VFATYLLKPL FPTCPVPEEA AKLVACLCVL
   181  LLTAVNCYSV KAATRVQDAF AAAKLLALAL IILLGFVQIG KGDVSNLDPN FSFEGTKLDV
   241  GNIVLALYSG LFAYGGWNYL NFVTEEMINP YRNLPLAIII SLPIVTLVYV LTNLAYFTTL
   301  STEQMLSSEA VAVDFGNYHL GVMSWIIPVF VGLSCFGSVN GSLFTSSRLF FVGSREGHLP
   361  SILSMIHPQL LTPVPSLVFT CVMTLLYAFS KDIFSVINFF SFFNWLCVAL AIIGMIWLRH
   421  RKPELERPIK VNLALPVFFI LACLFLIAVS FWKTPVECGI GFTIILSGLP VYFFGVWWKN
   481  KPKWLLQGIF STTVLCQKLM QVVPQET

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC7A5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
12
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
104 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 104 nTPM
  • esophagus: 96 nTPM
  • cerebral cortex: 66 nTPM
  • testis: 64 nTPM
  • midbrain: 54 nTPM
  • hypothalamus: 52 nTPM

Single-cell type

  • pdcs: 415 nCPM
  • retinal pigment epithelial cells: 401 nCPM
  • plasma cells: 292 nCPM
  • neutrophils: 267 nCPM
  • syncytiotrophoblasts: 203 nCPM
  • basal keratinocytes: 201 nCPM

Immune cell

  • plasmacytoid DC: 17 nTPM
  • T-reg: 1.6 nTPM
  • MAIT T-cell: 1.3 nTPM
  • basophil: 1 nTPM
  • gdT-cell: 1 nTPM
  • memory CD8 T-cell: 0.9 nTPM

Brain region

  • amygdala: 166 nTPM
  • thalamus: 158 nTPM
  • medulla oblongata: 144 nTPM
  • pons: 129 nTPM
  • midbrain: 129 nTPM
  • cerebral cortex: 125 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.51
gnomAD pLI
0.24
gnomAD missense Z
1.65
DepMap mean gene effect
-0.23
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SLC7A5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC7A5 as an antibody target. Whether an autoantibody or antibody against SLC7A5 could matter depends on whether native SLC7A5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC7A5 is annotated at the cell surface, where native SLC7A5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SLC7A5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC7A5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...